Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovarian cancer
Open Access
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (12), 1603-1608
- https://doi.org/10.1023/a:1008343519687
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2000
- First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidenceBritish Journal of Cancer, 1998
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Sequential or Alternating Doxorubicin and CMF Regimens in Breast Cancer With More Than Three Positive NodesJAMA, 1995
- Platinum resistance: Laboratory findings and clinical implicationsThe International Journal of Cell Cloning, 1993
- Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerThe Lancet, 1992
- Management of Small Cell Lung Cancer: A Summary of the Third International Association for the Study of Lung Cancer Workshop on Small Cell Lung CancerJNCI Journal of the National Cancer Institute, 1990
- Clinical Pharmacodynamics of High-Dose Methotrexate in Acute Lymphocytic LeukemiaNew England Journal of Medicine, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958